EGRX reports Ryanodex preclinical data in Ecstasy-induced hyperthermia: http://finance.yahoo.com/news/eagle-pharmaceuticals-announces-positive-initial-110000604.html Note: This program is separate from the Ryanodex program in exertional heatstroke.